Skip to main content
. 2013 Nov 22;20(2):294–300. doi: 10.1111/hae.12296

Figure 3.

Figure 3

Distribution of one-stage clotting assay results by dose level showing an approximate normal distribution for both rFVIIIFc and Advate®. (a) Advate® 0.8 IU mL−1, rFVIIIFc 0.87 IU mL−1; (b) Advate® 0.2 IU mL−1, rFVIIIFc 0.22 IU mL−1; (c) Advate® 0.05 IU mL−1, rFVIIIFc 0.054 IU mL−1. rFVIIIFc, recombinant factor VIII Fc fusion protein.